XML 85 R55.htm IDEA: XBRL DOCUMENT v3.10.0.1
Capital Management (Tables)
 12 Months Ended
Dec. 31, 2018
Corporate Information And Statement Of IFRS Compliance [Abstract]  
Schedule of Total Capital
For regulatory reporting purposes under the LICAT framework, there were further adjustments, including goodwill, non-life investments, and others as was prescribed by OSFI, to the total capital figure presented in the table below:
As at December 31,
2018
 
2017
 
Subordinated debt
 
$
3,039

 
$
3,437

Innovative capital instruments(1)
 
699

 
699

Equity:
 
 
 
 
Participating policyholders' equity
 
864

 
650

Preferred shareholders' equity
 
2,257

 
2,257

Common shareholders' equity
 
21,449

 
20,064

Total capital
 
$
28,308

 
$
27,107


(1) Innovative capital instruments are SLEECS issued by the SL Capital Trusts (Note 13). The SL Capital Trusts are not consolidated by us.